基質結合は,P450camcamへの NO結合を強化した NO結合を好みます
Alicja Franke1, Grazyna Stochel, Christiane Jung
1Institute for Inorganic Chemistry, University of Erlangen-Nürnberg, Egerlandstr. 1, 91058 Erlangen, Germany.
Journal of the American Chemical Society
|April 1, 2004
まとめ
サイトクロームP450camは窒素酸化物 (NO) を結合し,基板カンファーは結合運動を著しく変化させます. この研究では,圧力とスペクトルスコピーを用いてP450camのNO結合メカニズムを明らかにしています.
科学分野:
- バイオケミストリー バイオケミストリー
- 化学動力学 化学動力学
- スペクトロスコーピーは,スペクトロスコーピーを用います.
背景:
- サイトクロームP450cam (P450cam) は,様々な生物学的プロセスに関与する重要な酵素です.
- 酸化窒素 (NO) は,ヘムタンパク質と相互作用する重要なシグナル伝達分子です.
研究 の 目的:
- 基板 (1R-カンフォール) がNOとP450cam.ferricの結合動態に与える影響を調査する.
- 高圧技術を用いて,NOの結合と放出の反応機構を解明する.
主な方法:
- レーザーフラッシュフォトリシス
- ストップフロースペクトロスコピー
- 高圧研究 高圧研究
主要な成果:
- 基板の存在は,NOの結合と解離率を大幅に高めます.
- 基質のないP450camは,正の活性化エントロピーと体積で NO結合運動を遅らせる.
- カンフォール結合のP450camは,負の活性化エントロピーと体積で高速なNO結合を示し,結合形成が優位なメカニズムを示しています.
結論:
- 基板は,P450camのNO結合メカニズムに劇的な影響を及ぼし,解離的プロセスから結合的プロセスにシフトします.
- ボリュームプロファイルは,NOとヘムタンパク質の相互作用の分子レベルのメカニズムについての洞察を提供します.
- これらのメカニズムを理解することは,シトクロームP450酵素の生物学的機能にとって極めて重要です.
さらに関連する動画
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
関連する概念動画
01:27C4 Pathway and CAM
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
01:06Nuclear Overhauser Enhancement (NOE)
Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the nuclear Overhauser enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring spin-active...
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...